Literature DB >> 32224813

Differential Influence of Donor Age Depending on the Indication for Liver Transplantation-A Collaborative Transplant Study Report.

Philipp Houben1, Bernd Döhler2, Karl H Weiß3, Markus Mieth1, Arianeb Mehrabi1, Caner Süsal2.   

Abstract

BACKGROUND: Despite steadily increasing donor age, there are no general guidelines for the use of organs from elderly donors in liver transplantation. This study focuses on identifying the recipients who are less affected from an old-donor organ graft and conversely in whom a rather unfavorable outcome is expected because of high donor age.
METHODS: Forty-eight thousand two hundred sixty-one adult liver transplantations, performed between 2000 and 2017 and reported to the Collaborative Transplant Study, were analyzed.
RESULTS: The proportion of ≥65-year-old donors has risen to >33% in recent years. The donor age has an approximately linear influence on graft survival. On average, each year's rise in the donor age was associated with a 0.9% increase in the risk of graft loss (hazard ratio [HR], 1.009; P < 0.001). The impact of donor age was strong in patients with hepatitis C-related cirrhosis (HR, 1.013; P < 0.001), substantial in patients with alcoholic cirrhosis (HR, 1.007; P < 0.001) and rather weak in patients with hepatocellular carcinoma (HR, 1.003; P = 0.038). The increase in the risk of graft loss per year rise in donor age was 1.4% for 18 to 49 year olds, 1.0% for middle-aged, and only 0.4% for ≥60-year-old recipients (all P < 0.001).
CONCLUSIONS: Consequently, older recipients and especially patients with hepatocellular carcinoma seem to be less affected by an increased donor age, whereas the donor age is an important factor in all other patient groups.

Entities:  

Mesh:

Year:  2020        PMID: 32224813     DOI: 10.1097/TP.0000000000002970

Source DB:  PubMed          Journal:  Transplantation        ISSN: 0041-1337            Impact factor:   4.939


  7 in total

1.  Novel Composite Endpoint for Assessing Outcomes in Liver Transplantation: Arterial and Biliary Complication-Free Survival.

Authors:  Eric Savier; Yann De Rycke; Chetana Lim; Claire Goumard; Geraldine Rousseau; Fabiano Perdigao; Pierre Rufat; Chady Salloum; Laura Llado; Emilio Ramos; Josefina Lopez-Dominguez; Alba Cachero; Joan Fabregat; Daniel Azoulay; Olivier Scatton
Journal:  Liver Transpl       Date:  2021-09-07       Impact factor: 6.112

2.  How Old Is Old? An Age-Stratified Analysis of Elderly Liver Donors above 65.

Authors:  Philipp Houben; Eike Bormann; Felicia Kneifel; Shadi Katou; Mehmet Haluk Morgül; Thomas Vogel; Ralf Bahde; Sonia Radünz; Andreas Pascher; Hartmut Schmidt; Jens Gunther Brockmann; Felix Becker
Journal:  J Clin Med       Date:  2022-07-04       Impact factor: 4.964

3.  The Differential Influence of Cold Ischemia Time on Outcome After Liver Transplantation for Different Indications-Who Is at Risk? A Collaborative Transplant Study Report.

Authors:  Vladimir J Lozanovski; Bernd Döhler; Karl Heinz Weiss; Arianeb Mehrabi; Caner Süsal
Journal:  Front Immunol       Date:  2020-05-12       Impact factor: 7.561

4.  Rare Malignant Indications for Liver Transplantation: A Collaborative Transplant Study Report.

Authors:  Philipp Houben; Simon Schimmack; Christian Unterrainer; Bernd Döhler; Arianeb Mehrabi; Caner Süsal
Journal:  Front Surg       Date:  2021-12-03

5.  The New Age of Organ Donation-What Factors Have an Influence on the Attitude of Older People? An Attitudinal Survey in Southeastern Spain.

Authors:  Beatriz Febrero; Javier Almela-Baeza; Inmaculada Ros-Madrid; José Alfonso Arias; Juan José Ruiz-Manzanera; María Isabel Jiménez-Mascuñán; Pablo Ramírez
Journal:  Int J Environ Res Public Health       Date:  2022-07-12       Impact factor: 4.614

6.  Liver Transplant Recipient Characteristics Associated With Worse Post-Transplant Outcomes in Using Elderly Donors.

Authors:  Shingo Shimada; Tayseer Shamaa; Tommy Ivanics; Toshihiro Kitajima; Kelly Collins; Michael Rizzari; Atsushi Yoshida; Marwan Abouljoud; Dilip Moonka; Mei Lu; Shunji Nagai
Journal:  Transpl Int       Date:  2022-08-25       Impact factor: 3.842

7.  Liver transplantation for hepatocellular carcinoma using grafts from uncontrolled circulatory death donation.

Authors:  Anisa Nutu; Iago Justo; Alberto Marcacuzco; Óscar Caso; Alejandro Manrique; Jorge Calvo; Álvaro García-Sesma; María García-Conde; María Santos Gallego; Carlos Jiménez-Romero
Journal:  Sci Rep       Date:  2021-06-29       Impact factor: 4.379

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.